Physician-in-Chief
Jewish General Hospital
McGill University
Montreal, Quebec, Canada
Ernesto L. Schiffrin, C.M., MD, PhD, FRSC, FRCPC, FACP, is Physician-in-Chief at the Jewish General Hospital, Director of the Hypertension and Vascular Research Unit at the Lady Davis Institute, and Distinguished James McGill Professor and Vice-Chair, Department of Medicine, McGill University. Dr. Schiffrin's research has addressed mechanisms and treatment of high blood pressure, from molecules and cells to humans; the renin-angiotensin-aldosterone, endothelin and natriuretic peptide systems, inflammation and immunity, genes and microRNAs and their role on vascular function and injury. He is author of more than 620 peer-reviewed publications, many book chapters and editor of 4 books on molecular and clinical aspects of vascular disease and hypertension. His h-index is 135. Dr. Schiffrin was President of the Canadian Hypertension Society (1991–92); Chair of the High Blood Pressure Research Council, American Heart Association (2002–04); President, InterAmerican Society of Hypertension (2005–07); President, Quebec Hypertension Society (2009–11); President, International Society of Hypertension (2012–14); President, Hypertension Canada (2013-16). He was Associate Editor of Hypertension, journal of AHA (2003-15), and more recently is Editor-in Chief of the American Journal of Hypertension (2016-). Dr. Schiffrin has received many awards, including Senior Investigator Award of the Canadian Society of Internal Medicine (2003); the Distinguished Service Award, Canadian Hypertension Society (2004); Fellow, Royal Society of Canada (2006); Irvine Page-Alva Bradley Lifetime Achievement Award, High Blood Pressure Research Council, AHA (2007); Bjorn Folkow Award, European Society of Hypertension (2010); Member of the Order of Canada [C.M.] (2010); Excellence Award in Hypertension Research, AHA (2011); Robert Tigerstedt Distinguished Scientist Award, American Society of Hypertension (2013); Distinguished Scientist Award, Canadian Cardiovascular Society (2013); Distinguished Scientist Award, Canadian Society of Clinical Investigation (2015); Margolese National Prize on Heart Disorders (2016); Galien Research Prize Canada (2017); International Society of Hypertension Franz Volhard Award (2021); and 2021 Distinguished Scientist of the American Heart Association.
Thursday, October 27, 2022
3:45 PM – 4:00 PM EDT